conivaptan has been researched along with Critical Illness in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berger, K; Der-Nigoghossian, C; Lesch, C | 1 |
| Alberts, MJ; Bassin, SL; Bernstein, RA; Leibling, SM; Levasseur, K; Liebling, SM; Muro, K; Naidech, AM; Paparello, J | 1 |
| Balk, RA; Patel, GP | 1 |
1 review(s) available for conivaptan and Critical Illness
| Article | Year |
|---|---|
Recognition and treatment of hyponatremia in acutely ill hospitalized patients.
Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Critical Illness; Humans; Hyponatremia; Inpatients; Practice Guidelines as Topic; Pyrroles; Randomized Controlled Trials as Topic; Tolvaptan | 2007 |
1 trial(s) available for conivaptan and Critical Illness
| Article | Year |
|---|---|
Use of Conivaptan (Vaprisol) for hyponatremic neuro-ICU patients.
Topics: Adult; Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Critical Illness; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Glasgow Coma Scale; Humans; Hyponatremia; Injections, Intravenous; Intensive Care Units; Male; Middle Aged; Pilot Projects; Prospective Studies; Severity of Illness Index; Single-Blind Method; Sodium; Time Factors; Young Adult | 2010 |
1 other study(ies) available for conivaptan and Critical Illness
| Article | Year |
|---|---|
Effectiveness and Tolerability of Conivaptan and Tolvaptan for the Treatment of Hyponatremia in Neurocritically Ill Patients.
Topics: Adult; Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cohort Studies; Critical Illness; Female; Humans; Hypokalemia; Hyponatremia; Injections, Intravenous; Male; Middle Aged; Nervous System Diseases; Retrospective Studies; Sodium; Tolvaptan; Treatment Outcome | 2017 |